This country profile provides an overview of Madagascar’s progress in reaching those in need of mass NTD treatment based on 2017 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Download country profiles
Priorities for progress in Madagascar
- Recognising that the plague outbreak severely hampered implementation of preventive chemotherapy for elephantiasis in 2017, Madagascar should work to restore and further improve coverage across the endemic NTDs in 2018.
- Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.
Treatment coverage decreased from 44% in 2016 to 0% in 2017.
Madagascar does not require mass treatment for blinding trachoma.
Treatment coverage decreased from 92% in 2016 to 65% in 2017.
Treatment coverage increased from 43% in 2016 to 100% in 2017.
Madagascar does not require mass treatment for river blindness.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Madagascar.